As the world looks forward to a return to normalcy, indications are that the pandemic will have lasting impact even after the immediate crisis is over. RGA’s Matthew Easley offers suggestions on how companies can approach the longer-term financial implications of the...
Read More
Explore the important and growing world of hematopoietic stem cell transplantation in ReFlections. HSCT is the standard of care for many hematological malignancies and has found new utility in the treatment of immunological and hereditary conditions.
Read More
Head and neck cancers were the eighth most common cancers worldwide in 2018 and accounted for 3% of all cancer diagnoses and about 1.5% of cancer deaths in the U.S. alone. Epidemiologist Dr. Lauren Garfield discusses well known and emerging risk factors, survival rat...
Read More
Over the past three decades, the global prevalence of diabetes has risen to record levels. There has been a corresponding increase in the use of the glycated hemoglobin A1c (HbA1c) test to assess or detect diabetes. An increasing number of underwriters are now also c...
Read More
As the COVID-19 pandemic continues to spread worldwide, we are seeing healthcare delivery disrupted in unprecedented ways as public health authorities implement measures to limit close contact, movement, and travel. RGA's Dr. Steve Woh surveys the landscape, from&nbs...
Read More
Does the COVID-19 pandemic represent the perfect storm for cancer patients? Not only are many sufferers at increased risk of severe consequences from the virus, but the spread of COVID-19 has also reduced access to screening and care, observes RGA's Hilary Henly. She...
Read More
At a recent EMEA webinar, “Changing Consumer Behavior and Digital Distribution in the COVID-19 World,” Jonathan Hughes and Anthony Miller presented insights about how consumers’ behavior is evolving amid COVID-19 in the short and long term: What are their major conce...
Read More
RGA's Dr. John Lefebre draws on the words of Sir Winston Churchill when contemplating the likelihood of a second wave of COVID-19: “This is not the end. It is not even the beginning of the end. But it is, perhaps the end of the beginning”. What should insurers know?&...
Read More
Digital health behavior change applications are abundant, but low engagement statistics suggest they often don’t meaningfully respond to consumers’ motivations. It's easy for designers to see users’ long-term health needs while staying blind to the short-term motivat...
Read More
As broad-based community testing for COVID-19 grows, understanding and interpreting results will be essential, yet many still struggle to distinguish between test types. RGA offers a guide and has updated its
Read More
In this recording of the International Insurance Society (IIS) webinar “
Read More
Insurers are striving to better understand COVID-19-related mortality experience across age, underlying chronic health conditions, and gender – and yet finding and analyzing credible data has proven to be a daunting task.
In this recording of ...